Effects of the carnitine-acyltransferase inhibitor etomoxir on insulin sensitivity, energy expenditure and substrate oxidation in NIDDM.

Source:http://linkedlifedata.com/resource/pubmed/id/9370111

Download in:

View as

General Info

PMID
9370111